Sharma East India Hospitals & Medical Research Ltd

Dematerialisation processing status

• Dematerialisation requests received during the reporting period were confirmed to the depositories.
• Securities dematerialised have been listed on the stock exchanges where the earlier issued securities are listed.
• Physical certificates received for dematerialisation were mutilated and cancelled; Depositories' names substituted as registered owners within 15 days.

Sharma East India Hospitals & Medical Research Ltd: Trading window closed from Oct 1, 2026 for Standalone un-audited Financial Results for the quarter& half year ended September 30, 2026; shall open 48 hours after the announcement of Standalone un-audited Financial Results for the quarter& half year ended September 30, 2026, become generally available.

Financial highlights

• Revenue from operations and other income: 3,608.91 Lakhs in FY26; 3,018.59 in FY25.
• Profit before tax: 156.42 Lakhs in FY26; 141.28 in FY25.
• Net profit after tax: 124.27 Lakhs in FY26; 124.43 in FY25.
• Earnings per share (Basic & Diluted): ₹3.78 in FY26; ₹3.79 in FY25.
• Dividend not declared for FY2025-26.

Balance sheet snapshot

• Total assets: 3,291.82 Lakhs as at 31 March 2026.
• Total equity: 1,371.94 Lakhs as at 31 March 2026.
• Current borrowings: 655.21 Lakhs; Non-current borrowings: 73.61 Lakhs.
• Cash and cash equivalents: 45.43 Lakhs.

Dividends & reserves

• Dividend not declared; Surplus carried forward: 956.19 Lakhs.
• Previous surplus carried forward: 831.92 Lakhs.

Debt & liquidity

• Total borrowings: 728.82 Lakhs (current 655.21; non-current 73.61).
• Overdraft facility from banks: 611.79 Lakhs.
• Cash position: 45.43 Lakhs.

Governance & audit

• Statutory audit by M/s Gopal Sharma & Co; no qualifications.
• Secretarial audit by HSPN & Associates LLP; 5-year term.
• Rajeev Kumar resigned as Independent Director on 14-11-2025.
• Dr Pushpendra Prasad Garg appointed Independent Director till 2028.
• Promoter shareholding not fully dematerialized; noted in Annexure A.

Related party transactions

• All related party transactions were arm's length and ordinary course.
• Notable related parties include Sharma Hospitals Private Limited and Sharma Nursing Home & Bone Hospital Private Limited.

Outlook & risks

• Outlook remains cautious; management focused on service expansion.
• Key risks: technology upgradation, rising power tariffs, competition.

AGM details

• Date and time: 30 September 2026 at 3:00 PM via VC/OAVM.
• Record date for voting rights: 23 September 2026.
• Register of Members closed: 24–30 September 2026.
• Remote e-voting window: 27–29 September 2026.

Key resolutions

• Adoption of Audited Financial Statements for year ended March 31, 2026.
• Re-appointment of Radhika Sathe as Director, liable to retire by rotation.
• Fee for delivery of documents in requested mode: Rs 50 per document; advance payment.

Director changes

• Radhika Sathe to be re-appointed as director.
• Profile: Born 21 Oct 1987; BDS; appointed 30 May 2024; NIL shares.

Key Decisions

• Board approved Director's Report and annexures for FY ended March 31, 2026.
• Board fixed Sep 30, 2026, 3:00 PM IST for 37th AGM via VC/OAVM.
• Approved the Annual Report for FY 2025-2026 and the AGM Notice.
• Cut-off date to record voting entitlement fixed as Sep 23, 2026.
• E-voting window from Sep 27, 2026, 9:00 AM to Sep 29, 2026, 5:00 PM.
• Register of Members and Share Transfer Books to close Sep 24–30, 2026.

Audit status

• Independent limited review under SRE 2410 for quarter ended 30.06.2026.
• Not an audit; no audit opinion expressed.
• Conclusion: nothing has come to our attention that information is not disclosed per SEBI LODR.
• Report prepared in accordance with Ind AS and regulatory requirements.
• Auditors: Gopal Sharma & Co. Chartered Accountants, Jaipur.
• Period: Quarter ended 30.06.2026.

Financial results and audit review

• IND-AS standalone unaudited results for quarter ended 30 June 2026 approved.
• Limited Review Report on results issued by Gopal Sharma & Co. approved.
• Results published on jaipurhospital.co.in.
• Auditor states no audit opinion due to limited review.

Meeting Details

• Date: August 12, 2026 (Wednesday).
• Location: registered office, Jaipur; time not disclosed.

Key Agenda Items

• Approve IND-AS compliant standalone unaudited financial results with Limited Review Report for quarter ended 30 June 2026.
• Any other business with permission of the Chair and with consent of majority directors, including an Independent Director.

Other Notes

• Trading window closed from July 1, 2026 until 48 hours after unaudited results declaration.

Dematerialisation status

• Dematerialisation requests processed and confirmed to depositories during the quarter; dematerialised securities listed on exchanges.
• Physical certificates received for dematerialisation were mutilated and cancelled after verification; depository registered owner updated within 15 days.